Top compounds associated with response to NRDC


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.037 0.3
mRNA PF-750 CTRPv2 pan-cancer AAC 0.04 0.3
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA PF-3758309 CTRPv2 pan-cancer AAC 0.046 0.3
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA ML312 CTRPv2 pan-cancer AAC -0.074 0.3
mRNA hyperforin CTRPv2 pan-cancer AAC 0.04 0.3
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.039 0.3
mRNA FR-180204 GDSC1000 pan-cancer AAC -0.036 0.3
mRNA AS605240 GDSC1000 pan-cancer AAC -0.035 0.3
Download CSV